What type of study is this?

This is a Retrospective study (also classified as: Longitudinal Cohort Study).

Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort study finds ARB monotherapy slightly improves renal function over SGLT2i/ACEi, suggesting treatment considerations.

ARB monotherapy was associated with better renal function markers than SGLT2i/ACEi therapy, with higher eGFR and lower serum creatinine levels.
In this longitudinal study, 60.8% of ARB users maintained negative albuminuria compared to 73.1% on combination therapy, indicating renal stability.
With a sample of 126 patients, renal biomarkers were rigorously analyzed using t-tests and ANOVA to derive comparative effectiveness.
These results emphasize the need for further studies to understand the long-term renal effects of varying diabetes treatment regimens.

Ngai et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort study finds ARB monotherapy slightly improves renal function over SGLT2i/ACEi, suggesting treatment considerations.

ARB monotherapy was associated with better renal function markers than SGLT2i/ACEi therapy, with higher eGFR and lower serum creatinine levels.
In this longitudinal study, 60.8% of ARB users maintained negative albuminuria compared to 73.1% on combination therapy, indicating renal stability.
With a sample of 126 patients, renal biomarkers were rigorously analyzed using t-tests and ANOVA to derive comparative effectiveness.
These results emphasize the need for further studies to understand the long-term renal effects of varying diabetes treatment regimens.

Ngai et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark